Prelude Capital Management’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-38,918
Closed -$83.7K 1156
2024
Q2
$83.7K Sell
38,918
-1,382
-3% -$2.97K 0.01% 1023
2024
Q1
$131K Buy
+40,300
New +$131K 0.01% 1063